ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Obesity
Foot Ulcer
Overweight

Diabetes trials near Paris, Île-de-France, FRA:

Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in Patients With Diabetes (ICP-COVERPATCH)

and night, providing valuable data to help individuals manage their diabetes more efficiently. Many people face difficulties in keeping thei...

Not yet enrolling
Diabetes
Device: Use of COVER patchs for continuous glucose monitoring sensor
CAPTEUR PROTECT

Corbeil-Essonnes, France and 6 other locations

Type 1 diabetes (T1D) is caused by the destruction of insulin-producing cells by effector T cells (Teffs), due to a deficiency of regulatory...

Enrolling
Type 1 Diabetes
Drug: Cyclosporin
Drug: ILT101

Phase 2

Assistance Publique - Hôpitaux de Paris

Paris, France

The goal of this randomized controlled study is to assess the clinical performance and safety of Hedia Diabetes Assistant in adults with typ...

Enrolling
Type 1 Diabetes Mellitus (T1DM)
Device: Hedia Diabetes Assistant
Hedia

Paris, France and 5 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

Paris, France and 89 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Active, not recruiting
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Paris, France and 35 other locations

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Bondy, France and 78 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

Paris, France and 48 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Paris, Île-de-France, France and 648 other locations

This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous gluco...

Active, not recruiting
Diabetes Mellitus, Type 1
Device: Omnipod 5 System
Insulet

Paris, France and 18 other locations

Evolucare OphtAI is a medical device offering automated, artificial intelligence powered, screening capabilities for Diabetic Retinopathy, D...

Enrolling
Diabetic Macular Edema
Diabetic Retinopathy
Device: Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device
Evolucare Technologies

Paris, Île De France, France and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems